The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Apr 2020 07:30

RNS Number : 5304J
Circassia Pharmaceuticals Plc
14 April 2020
 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc

Ian Johnson Executive Chairman

Michael Roller Chief Financial Officer

c/o FTI Consulting

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

 

Tel: +44 (0)20 7418 8900

finnCap (Joint Broker)

Geoff Nash / Alice Lane

 

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin

Tel: +44 (0) 20 3727 1000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Michael Roller

3. Jonathan Emms

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Pharmaceuticals plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. 22.85p

2. 22.683p

3. 23.2p

1. 200,000

2. 200,000

3. 300,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2020-04-09

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGLGDSCDBDGGS
Date   Source Headline
31st Jan 20184:03 pmRNSTotal Voting Rights
17th Jan 20182:42 pmRNSBlock Listing Six Monthly Return
17th Jan 20182:37 pmRNSNotification of Major Holdings
8th Jan 20187:00 amRNSTR-1: Notification of major holdings
5th Jan 20185:31 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSTotal Voting Rights
19th Dec 20175:48 pmRNSNotification of Major Holdings
4th Dec 20177:00 amRNSTudorza® Meets Primary Endpoints in ASCENT Study
30th Nov 20172:53 pmRNSTotal Voting Rights
29th Nov 20177:00 amRNSCircassia Welcomes New NICEAsthma Guidelines
31st Oct 20175:18 pmRNSTotal Voting Rights Update
16th Oct 201711:39 amRNSNotification of Major Holdings
29th Sep 201712:13 pmRNSTotal Voting Rights Update
27th Sep 20177:00 amRNSInterim results six months ended 30 June 2017
18th Sep 20172:52 pmRNSNotification of Major Holdings
18th Sep 20172:19 pmRNSNotification of Major Holdings
12th Sep 20177:00 amRNSEuropean Launch of NIOX VERO® Nasal Mode
7th Sep 20177:00 amRNSPrimary Endpoints Met in AMPLIFY Phase III Study
1st Sep 20175:21 pmRNSNotification of Major Holdings
31st Aug 201712:52 pmRNSTotal Voting Rights
24th Aug 20174:06 pmRNSNotice of Interim Results
31st Jul 20177:00 amRNSTotal Voting Rights Update
21st Jul 20178:52 amRNSNotification of Major Holdings
17th Jul 20176:28 pmRNSDirector/PDMR Shareholding
14th Jul 201712:29 pmRNSNotification of Major Holdings
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
30th Jun 20177:00 amRNSTotal Voting Rights Update
29th Jun 20176:08 pmRNSNotification of Major Interest in Shares
27th Jun 201711:48 amRNSNotification of Major Interest in Shares
26th Jun 20174:27 pmRNSNotification of Major Interest in Shares
15th Jun 20175:40 pmRNSNotification of Major Interest in Shares
5th Jun 20175:36 pmRNSDirector/PDMR Shareholding
31st May 201710:59 amRNSTotal Voting Rights Update
31st May 20177:00 amRNSBlock Listing Application
26th May 201711:35 amRNSResult of AGM 2017
26th May 20177:00 amRNSHolding(s) in Company
28th Apr 20175:20 pmRNSAnnual Report and Notice of Annual General Meeting
28th Apr 20173:15 pmRNSTotal Voting Rights Update
25th Apr 20177:02 amRNSNon-Executive Director Retirements
25th Apr 20177:00 amRNSPreliminary Results for Year Ended 31 Dec 2016
18th Apr 20176:09 pmRNSHolding(s) in Company
18th Apr 20174:51 pmRNSNotification of Major Interest in Shares
18th Apr 201710:20 amRNSNotification of Major Interest in Shares
18th Apr 20177:00 amRNSTop-Line Results of House Dust Mite Allergy Study
13th Apr 20176:02 pmRNSHolding(s) in Company
13th Apr 20175:57 pmRNSHolding(s) in Company
12th Apr 20175:34 pmRNSNotification of Major Interest in Shares
12th Apr 20179:00 amRNSNotice of Results
12th Apr 20178:30 amRNSCompletion of Transaction and Admission to Trading
11th Apr 20179:00 amRNSEarly Termination of HSR Waiting Period Granted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.